Patent · US Active

Polypeptide composition

US12305202B2 · kind B2 · utility

0Cited by
5References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 27, 2019
Grant dateMay 20, 2025
Priority date
Expiry dateMar 9, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/55
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A polypeptide composition, and methods of making the same, may include a first polypeptide and a second polypeptide, wherein the first polypeptide comprise a first toxin fragment and a first intein fragment, the second polypeptide comprise a second toxin fragment and a second intein fragment, the first polypeptide is different from the second polypeptide; the first toxin fragment and the second toxin fragment are non-biotoxic; the first polypeptide and the second polypeptide may make the first toxin fragment and the second toxin fragment into biotoxic toxins by an interaction of the first intein fragment and the second intein fragment. Kits may include such first and second polypeptides, and such compositions and kits may be used in treating tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.